Clinical studies recruiting near Cottingham

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Sele
NA · Hull University Teaching Hospital NHS Trust · Alimentiv Inc. · NCT07363044 Study on Optimal Temperature During Cardiopulmonary Bypass (THERMIC-4)
NA · Castle Hill Hospital, Hull University Teaching Hospitals NHS · University of Leicester · NCT05996120 Exercise for Improving Long-course Chemoradiotherapy Efficacy in People With Locally Advanced Rectal Cancer
EARLY_Phase 1 · Castle Hill Hospital · University of Hull · NCT06276686 Volatile Organic Compounds as Breath Biomarkers in Squamous Oesophageal Neoplasms
Phase N/A · Hull University Teaching Hospitals NHS Trust · Imperial College London · NCT06169163 An Observational Study Using Novel Questionnaire to Characterize Cough Phenotypes in Patients With Chronic Cough
Phase N/A · Redspiratory Medicine, First Floor, Daisy Building, Castle H · Hull University Teaching Hospitals NHS Trust · NCT06376448 A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurre
Phase 3 · Castle Hill Hospital · Janssen Research & Development, LLC · NCT07276399 A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD
Phase 3 · Castle Hill Hospital · Hoffmann-La Roche · NCT05878769 Hydra Registry - UK
Phase N/A · Castle Hill Hull · Sahajanand Medical Technologies Limited · NCT06507579 Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for L
Phase 2/Phase 3 · Hull University Teaching Hospitals NHS Trust · BioNTech SE · NCT06712316 A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary
Phase 2 · Research Site · AstraZeneca · NCT07082738 Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated S
Phase 3 · Hull University Teaching Hospitals NHS Trust · BioNTech SE · NCT06712355 Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
Phase 3 · Hull University Teaching Hospitals NHS Trust · Icahn School of Medicine at Mount Sinai · NCT04045665 Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bulevirtide
Phase 2/Phase 3 · Castle Hill Hospital · Mirum Pharmaceuticals, Inc. · NCT07454837 Tracking Mutations in Cell Free Tumour DNA to Predict Relapse in Early Colorectal Cancer
Phase N/A · Castle Hill Hospital · Royal Marsden NHS Foundation Trust · NCT04050345 A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopul
Phase 3 · Research Site · AstraZeneca · NCT06283966 A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D
Phase 3 · Research Site · AstraZeneca · NCT06883305 Machine Learning in Quantitative Stress Echocardiography
Phase N/A · Castle Hill Hospital · Hull University Teaching Hospitals NHS Trust · NCT04193475 A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
Phase 2 · Research Site · AstraZeneca · NCT07652658 Personalized Medicine for Advanced Biliary Cancer Patients
Phase 3 · Castle Hill Hospital · UNICANCER · NCT05615818 Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Neg
Phase 3 · Hull University Teaching Hospitals NHS Trust · Gilead Sciences · NCT05633654 Surgical vs Transcatheter Aortic Valve Replacement in YOUNG Patients
NA · Castle Hill Hospital, Hull University Teaching Hospitals NHS · Ceric Sàrl · NCT06861361 A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Ute
Phase 3 · Castle Hill Hospital · BioNTech SE · NCT06340568 A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasiv
Phase 3 · Hull University Teaching Hospitals NHS Trust · Janssen Research & Development, LLC · NCT06919965 Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Phase 3 · Castle Hill Hospital · Cytokinetics · NCT06736574 A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)
Phase 3 · Hull University Teaching Hospitals · Mirum Pharmaceuticals, Inc. · NCT07200908 Fosfomycin I.v. for Treatment of Severely Infected Patients
Phase N/A · Hull & East Yorkshire Hospitals NHS Trust · Infectopharm Arzneimittel GmbH · NCT02979951 Tumour Regulatory Molecules in Early Pancreatic Cancer Detection
Phase N/A · Castle Hill Hospital, Hull University Teaching Hospitals NHS · Hull University Teaching Hospitals NHS Trust · NCT03536793 ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Phase 3 · Hull and East Yorkshire Hospitals NHS Trust - Castle Hill Ho · BioNTech SE · NCT07173751 Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Car
Phase 3 · Research Site · Arcus Biosciences, Inc. · NCT07011719 A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Phase 3 · Site GB44010 · Astellas Pharma Global Development, Inc. · NCT06901531

Look up another city

Look up another condition